Prophase Labs, INC. (PRPH) — 8-K Filings

All 8-K filings from Prophase Labs, INC.. Browse 38 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (38)

ProPhase Labs Files 8-K — Dec 19, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on December 19, 2025, reporting an event that occurred on December 12, 2025. The filing pertains to "Other Events" and "Financi
ProPhase Labs Files 8-K on Shareholder Votes & Financials — Nov 26, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on November 26, 2025, reporting on matters submitted to a vote of security holders and financial statements. The earliest event
8-K Filing — Nov 25, 2025
ProPhase Labs Files 8-K on Financials — Nov 19, 2025 Risk: low
On November 19, 2025, ProPhase Labs, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along
ProPhase Labs Enters Material Definitive Agreement — Oct 15, 2025 Risk: medium
On October 9, 2025, ProPhase Labs, Inc. entered into a material definitive agreement. The company, formerly known as Quigley Corp, is incorporated in Delaware a
ProPhase Labs Enters Material Definitive Agreement — Sep 18, 2025 Risk: medium
On September 18, 2025, ProPhase Labs, Inc. entered into a material definitive agreement. The filing does not provide specific details on the agreement, its term
ProPhase Labs Files 8-K with Key Corporate Changes — Sep 15, 2025 Risk: medium
On September 15, 2025, ProPhase Labs, Inc. filed an 8-K report detailing several significant corporate events. These include the entry into a material definitiv
ProPhase Labs Terminates Material Agreement — Aug 28, 2025 Risk: medium
ProPhase Labs, Inc. filed an 8-K on August 28, 2025, to report the termination of a material definitive agreement. The filing does not specify the counterparty
ProPhase Labs Files 8-K Report — Aug 19, 2025 Risk: low
On August 19, 2025, ProPhase Labs, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regu
ProPhase Labs Files 8-K on Financials — Aug 13, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on August 13, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disc
ProPhase Labs Announces Director and Officer Changes — Aug 6, 2025 Risk: medium
ProPhase Labs, Inc. announced on August 6, 2025, changes related to its board of directors and executive officers. The filing indicates a departure of directors
ProPhase Labs Files 8-K — Jul 29, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on July 29, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Event
ProPhase Labs Enters Material Agreement, Reports Financial Obligations — Jul 28, 2025 Risk: medium
ProPhase Labs, Inc. announced on July 28, 2025, that it entered into a material definitive agreement. The company also reported the creation of a direct financi
ProPhase Labs Files 8-K — Jul 25, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on July 25, 2025, reporting on matters submitted to a vote of security holders and other events. The filing does not contain sp
ProPhase Labs Files 8-K with Corporate Updates — Jul 23, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on July 23, 2025, reporting on various events and financial statements. The filing details the company's principal executive of
ProPhase Labs Files 8-K Report — Jul 21, 2025 Risk: low
On July 21, 2025, ProPhase Labs, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regula
ProPhase Labs Faces Delisting Concerns — Jul 1, 2025 Risk: high
ProPhase Labs, Inc. filed an 8-K on July 1, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of
ProPhase Labs Faces Delisting Concerns — Jun 26, 2025 Risk: high
ProPhase Labs, Inc. filed an 8-K on June 26, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indica
ProPhase Labs Appoints New Directors, Adjusts Executive Pay — Jun 25, 2025 Risk: medium
ProPhase Labs, Inc. announced on June 25, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new director
ProPhase Labs Files 8-K on Financials — May 20, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on May 20, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclos
ProPhase Labs Files 8-K on Financials — Mar 31, 2025 Risk: low
ProPhase Labs, Inc. filed an 8-K on March 31, 2025, reporting on its results of operations and financial condition. The filing also includes financial statement
ProPhase Labs Appoints New Directors and CMO — Feb 21, 2025 Risk: medium
ProPhase Labs, Inc. announced on February 17, 2025, changes in its executive and director roles. The company elected two new directors, Dr. David G. Nichols and
ProPhase Labs Announces Board and Officer Changes — Feb 13, 2025 Risk: medium
ProPhase Labs, Inc. announced on February 7, 2025, changes related to its board of directors and officers. The filing indicates a departure of directors or cert
ProPhase Labs Enters Material Definitive Agreement — Jan 30, 2025 Risk: medium
On January 29, 2025, ProPhase Labs, Inc. entered into a material definitive agreement. The filing does not provide specific details about the agreement or any a
ProPhase Labs (PRPH) Files 8-K with Office Location — Jan 23, 2025 Risk: low
On January 16, 2025, ProPhase Labs, Inc. (PRPH) filed an 8-K report. The filing confirms the company's principal executive offices are located at 711 Stewart Av
ProPhase Labs Faces Nasdaq Delisting Warning — Dec 27, 2024 Risk: high
ProPhase Labs, Inc. received a notice on December 26, 2024, indicating it failed to meet a continued listing rule or standard for the Nasdaq Capital Market. The
ProPhase Labs Enters Material Definitive Agreement — Nov 13, 2024 Risk: medium
ProPhase Labs, Inc. announced on November 7, 2024, that it entered into a material definitive agreement. The company, formerly known as Quigley Corp, is incorpo
ProPhase Labs Files 8-K — Nov 7, 2024 Risk: low
ProPhase Labs, Inc. filed an 8-K on November 7, 2024, to report other events and financial statements. The filing does not contain specific details about the na
ProPhase Labs Changes Auditors to EisnerAmper LLP — Oct 18, 2024 Risk: medium
ProPhase Labs, Inc. announced on October 18, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered public a
ProPhase Labs Changes Independent Auditor — Oct 4, 2024 Risk: medium
ProPhase Labs, Inc. filed an 8-K on October 4, 2024, reporting a change in its certifying accountant as of September 30, 2024. The company previously engaged Wi
ProPhase Labs Faces Nasdaq Delisting Threat Again — Sep 26, 2024 Risk: high
ProPhase Labs, Inc. announced on September 20, 2024, that it received a notice from Nasdaq indicating a failure to meet the minimum bid price requirement for co
ProPhase Labs Secures $1.5M Loan — Aug 21, 2024 Risk: medium
On August 15, 2024, ProPhase Labs, Inc. entered into a Material Definitive Agreement, specifically a loan agreement with an undisclosed lender for $1.5 million.
ProPhase Labs Files 8-K on Financials — Aug 14, 2024 Risk: low
ProPhase Labs, Inc. filed an 8-K on August 14, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD disc
ProPhase Labs Files 8-K on Security Holder Vote — Jun 21, 2024 Risk: medium
On June 20, 2024, ProPhase Labs, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing indicates a meeting
ProPhase Labs Files 8-K on Financials — May 9, 2024 Risk: low
ProPhase Labs, Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosu
ProPhase Labs, Inc. Files Material Definitive Agreement 8-K — Apr 18, 2024 Risk: medium
On April 18, 2024, ProPhase Labs, Inc. filed an 8-K to report a material definitive agreement. The filing does not contain specific details about the agreement,
ProPhase Labs Files 8-K on Financials and Operations — Mar 15, 2024 Risk: low
ProPhase Labs, Inc. filed an 8-K on March 15, 2024, reporting on its results of operations and financial condition. The filing also includes information related
ProPhase Labs Files 8-K on Dec 28 Event; Leadership/Comp Changes Possible — Jan 4, 2024
ProPhase Labs, Inc. filed an 8-K on January 4, 2024, reporting an event that occurred on December 28, 2023. This filing is a standard current report under the S

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX